European Nanotechnology Experts Visit NCL; Harmonize Best Practices for Nanomedicine Collaboration in Europe

European nanotechnology experts studied best practices and methods at the Nanotechnology Characterization Laboratory (NCL), and shared their own knowledge with NCL scientists before heading home to kick-start an NCL-like operation in Europe.


The European Union Nanomedicine Characterisation Laboratory (EUNCL) plans to open for business in mid-2016 with funding from the European Commission and support from the NCL and organizations in France, Germany, Ireland, Italy, Norway, Switzerland, and the United Kingdom.
“No reason to reinvent the wheel,” said Luigi Calzolai, Ph.D., of the Joint Research Centre of the European Commission in Italy. He and his colleagues spent two weeks onsite learning from NCL’s 12 years of experience in developing and implementing standards-based processes for characterizing nanoparticles for use in precision medicines against cancer.

“The European Union wants to bridge gaps in nanomedicine research and build a pan-European infrastructure for its characterization and translational opportunities,” said Adriele Prina-Mello, Ph.D., of Trinity College Dublin. Prina-Mello is also an executive board member and chair of the Toxicology, Characterisation and Regulation Issues working group at the European Technology Platform for Nanomedicine.

more ...

Events where you meet EUNCL

More Events ...

European Nanomedicine Characterisation Laboratory (EUNCL)

Call for Proposals!


  • NCI-NCL – Open position
    The NCL is looking for an experienced analytical chemist to add to our team.
  • EUNCL ExBo Meeting in Liverpool
    The EUNCL ExBo met on 22nd and 23rd November 2018 at University of Liverpool to discuss the actual status of the work in the project and especially in the TNA. The CET and TNA management updated the ExBo on the on-going and the further work planned. The discussion on all questions raised during the meeting was very extensive and important decisions were taken for the last year of the project duration.
  • CLINAM 2018 with EUNCL Participation
    It was the 11th Summit of its kind. CLINAM again welcomed the participants from the community of nanomedicine, targeted drug delivery and precision medicine and bring together the pioneers and worldwide opinion leaders, not only to learn and discuss but also to develop new ideas, create new collaborative projects and shape the future of medicine.

More News ...